Although breast cancer stem cells (BCSCs) display plasticity transitioning between quiescent
mesenchymal-like (M) and proliferative epithelial-like (E) states, how this plasticity is …

Triple-negative breast cancers (TNBCs) are more common among African-ancestry
populations, such as African Americans and western, sub-Saharan Africans, compared with …

Introduction Triple-negative breast cancer (TNBC) is more common among African American
(AA) and western sub-Saharan African breast cancer (BC) patients compared with White/…

To address health disparities faced by Black patients with cancer, it is critical that researchers
conducting cancer clinical trials (CCTs) equitably recruit and retain Black participants, …

Identifying better predictive and prognostic biomarkers for the diagnosis and treatment of
triple negative breast cancer (TNBC) is complicated by tumor heterogeneity ranging from …

Purpose Breast cancer, the most common cancer worldwide, is the leading cause of cancer
mortality in Ghanaian women. Previous studies find Ghanaian women are diagnosed at a …

Purpose Triple-negative breast cancer (TNBC) is an aggressive subtype most prevalent
among women of Western Sub-Saharan African ancestry. It accounts for 15–25% of African …

Objective: To investigate subtype-specific risk of germline alleles associated with triple
negative breast cancer (TNBC) in African ancestry populations. Background: Breast cancer (BC) …

Cancer genomes from patients with African (AFR) ancestry have been poorly studied in clinical
research. We leverage two large genomic cohorts to investigate the relationship between …

Breast cancers that have negative or extremely low expression of estrogen receptor and
progesterone receptor and non‐amplification of human epidermal growth factor receptor‐2 ( …